James Ebertowski
Papers
1
Total Citations
33
H-Index
1
About
Dr. James Ebertowski is a urologic surgeon whose research centers on optimizing perioperative pain management, particularly in minimally invasive urologic surgery. His most impactful work addresses the critical question of whether costly long-acting liposomal bupivacaine offers meaningful advantages over standard, less expensive bupivacaine for pain control after laparoscopic procedures. In his landmark 2015 randomized controlled trial—cited 33 times—Dr. Ebertowski directly compared these two agents in a prospective, patient-blinded study. This investigation provided pivotal evidence on the efficacy and cost-effectiveness of liposomal bupivacaine, helping to guide clinical decision-making in an era increasingly focused on value-based care and enhanced recovery after surgery (ERAS) protocols. By rigorously testing a premium-priced intervention against a traditional standard, his work has informed both surgical practice and hospital resource allocation. Dr. Ebertowski’s contributions are particularly valuable for surgeons and anesthesiologists seeking to balance optimal patient comfort with fiscal responsibility, making him a key voice in the ongoing effort to refine multimodal analgesia strategies in urology.
Research Focus
Key Achievements
Top Papers
- 1